Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Relative Value
The Relative Value of one
Wuhan Easy Diagnosis Biomedicine Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 18.7 CNY,
Wuhan Easy Diagnosis Biomedicine Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Wuhan Easy Diagnosis Biomedicine Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
4.1B CNY | 11.7 | 578.3 | -18.1 | -18.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.7B USD | 4.5 | 30.5 | 17.3 | 23.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176B USD | 17.4 | 61.4 | 46.7 | 57.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.5B USD | 5.8 | 44.9 | 22.7 | 27.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
126B USD | 3.5 | 27.1 | 14.6 | 21.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.2B USD | 5.5 | 38 | 22.6 | 30.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.6B EUR | 2 | 22.3 | 12.3 | 17.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
53B USD | 2.4 | 29.7 | 11.3 | 19.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.5B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.3B USD | 7.9 | 44.5 | 24.7 | 27 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.5B USD | 1.9 | 18.4 | 13 | 15.7 |